Anti-endothelial cell antibodies (AECA) are commonly detectable in diseases associated with vascular injury, including systemic lupus erythematosus (SLE), systemic sclerosis, Takayasu's arteritis, Wegener's granulomatosis, Behçet's syndrome and transplant arteriosclerosis. Here, we explore the hypothesis that these antibodies might augment polymorphonuclear leukocyte (PMN) adhesion to endothelium in inflammation. Initially, we established that a mouse IgG mAb bound to EC significantly increased PMN adhesion to cytokine-stimulated endothelium in an FcγRIIa-dependent manner. Neutralizing antibodies, and adenoviral transduction of resting EC, demonstrated that the combination of E-selectin, CXCR1/2 and β 2 integrins is both necessary and sufficient for this process. We observed an identical mechanism using AECA IgG isolated directly from patients with SLE. Assembled immune-complexes also enhanced PMN adhesion to endothelium, but, in contrast to adhesion due to AECA, this process did not require CXCR1/2, was not inhibited by pertussis toxin and was FcγRIIIb rather than FcγRIIa dependent. These data are the first to demonstrate separate non-redundant FcγRIIa and FcγRIIIb-mediated mechanisms by which EC-bound monomeric IgG and assembled immune-complexes amplify leukocyte adhesion under dynamic conditions. Furthermore, the observation that FcγRIIa and CXCR1/2 co-operate to enhance PMN recruitment in the presence of AECA suggests a mechanism whereby AECA may augment tissue injury during inflammatory responses.
INTRODUCTION
The recruitment of circulating polymorphonuclear leukocytes (PMN) to sites of inflammation is mediated by a series of adhesion and activation steps, known as the "adhesion cascade" 1 . Thus, selectins are largely responsible for initial tethering of flowing PMN to endothelium, and also mediate subsequent PMN rolling on the endothelial surface. Activation of rolling PMN leads to leukocyte arrest via modulation of the affinity and avidity of β 2 integrins, with LFA-1 (CD11a/CD18) acting primarily to slow rolling and to promote arrest, and Mac-1 (CD11b/CD18) acting to stabilize adhesion [2] [3] [4] [5] . The capacity of endothelial cells (EC) to support these interactions with PMN is stimulated by cytokines such as TNFα and IL-1β, which induce expression of a large number of adhesion molecule, chemottractant and other proinflammatory genes, including E-selectin, chemokines (eg IL-8) and ICAM-1 6;7 .
Antibodies that react with the surface of vascular endothelial cells (anti-endothelial cell antibodies, AECA) are found in a variety of diseases associated with vascular injury, including SLE, systemic sclerosis, Takayasu's arteritis, Wegener's granulomatosis, Behçet's syndrome and transplant arteriosclerosis 8;9 . A number of mechanisms have been proposed whereby IgG binding to EC may exert pathogenic effects, including the induction of EC inflammatory activation and thrombogenicity, the stimulation of leukocyte free-radical production and cellular cytotoxicity, and the induction of EC apoptosis [10] [11] [12] [13] [14] .
Interactions between circulating human PMN and immune-complexes are mediated via two low affinity Fcγ receptors, FcγRIIa (CD32a) and FcγRIIIb (CD16b), which are both thought to form homodimers and have distinct membrane anchoring and
For personal use only. on . by guest www.bloodjournal.org From signalling capacities [15] [16] [17] [18] [19] . The cytoplasmic domain of FcγRIIa has a specialised immunoreceptor tyrosine based activation motif, which upon receptor cross-linking becomes tyrosine-phosphorylated by Src-family tyrosine kinases such as Fgr and Lyn [20] [21] [22] . Subsequent receptor association with Syk kinase and phosphoinositide 3-kinase results in phagocytosis, degranulation, respiratory burst and antibody-dependent cellular cytotoxicity 23 . Cross-talk between PMN Fcγ receptors and β 2 integrins, particularly Mac-1 (CD11b/CD18, CR3), is well known to occur 33 . Under static conditions, initial adhesion to surfaces coated with immune-complexes is independent of β 2 integrins, but β 2 integrins are needed for cell spreading and the maintenance of adhesion [34] [35] [36] .
Recently, however, Coxon et al reported a much faster effect of FcγRIIIb ligation on PMN adhesion to a glass surface coated with immune-complexes, showing that FcγRIIIb is expressed on the tips of PMN microvilli and well placed to interact with IgG under dynamic conditions 37 . Furthermore, they found that FcγRIIIb mediates selectin-independent capture of PMN under flow conditions and the immediate triggering of Mac-1-dependent arrest 37 . This has suggested an important mechanism whereby immune-complexes may trigger vascular injury. 
MATERIALS AND METHODS

Antibodies & Reagents.
Mouse anti-endoglin (mAb RMAC8), anti-L-selectin (mAb DREG-56), anti-E-selectin (mAb 1.2B6), anti-ICAM-1 (mAb 6.5B6), anti-FcγRIIIb (mAb 3G8), anti-FcγRIIa (mAb IV.3), anti-CD18 (mAb TS1/18), and anti-LFA-1 (mAb TS1/22) were purified from hybridoma supernatants. Anti-CD11b mAb ICRF-44 was a gift from Dr Nancy Hogg (Cancer Research UK, London, UK). Anti-CXCR-1 (clone 501) and anti-CXCR-2 (clone 19) were from Biosource (Nivelles, Belgium).
Anti-E-selectin mAb SPLAT-1 (human IgG 4 ) was a gift from Dr Martyn Robinson (UCB Celltech, Slough, UK). Control mouse mAb MOPC21 was from Sigma-Aldrich (Poole, UK). Fab fragments of mAb 3G8 were generated using the ImmunoPure Fab preparation kit (Pierce, Rockford, USA). Biotinylated anti-human IgG/IgM and antihuman IgG was from Jackson Immunological (West Grove, USA). FITC-conjugated goat anti-mouse Ig and sheep anti-rabbit Ig were from Dako (Ely, UK). Polyclonal rabbit anti-mouse Ig serum (RbAMIg) was obtained by immunising rabbits with mouse IgG. Biotinylated antibodies against human IgG 1 , IgG 2 , IgG 3 and IgG 4 were from Sigma-Aldrich. AlexaFluor conjugated streptavidin, anti-mouse Ig and antirabbit Ig antisera were from Invitrogen (Carlsbad, USA). TNFα was obtained from UCB Celltech. Other cell culture reagents were from Sigma-Aldrich.
Generation of adenoviral constructs E-selectin (adE-selectin) and IL-8 (adIL-8) adenoviral constructs were generated using the ViraPower ™ adenoviral system (Invitrogen). An ICAM-1 adenovirus construct (AdICAM-1) was donated by Dr
Charlotte Lawson (Imperial College). Adhesion assays under flow. Adhesion assays were conducted as described 38 . Briefly, HMEC-1 monolayers were assembled in a parallel plate flow chamber and placed onto the stage of a 37°C prewarmed inverted Nikon Diaphot 300 florescence microscope connected to a JVC TK-C1360 colour video camera. PMN (10 6 /ml) or HL60 cells (3x10 5 /ml) were perfused over EC monolayers at the indicated shear.
After 2 min, 10 fields of view were recorded for 10 secs and analysed for leukocyte adhesive interactions using Cell Motion tracking software (Ed Marcus Laboratories, City). HL60 rolling on E-selectin was determined to be between 3-100 µm/sec, whereas PMN roll at a slower rate and thresholds were set at 2-50 µm/sec. In antibody Figure 1E ). IgG-mediated HL60 cell arrest was dependent upon the concentration of RMAC8 perfused over the monolayers ( Figure   1F ).
IgG-enhanced leukocyte adhesion to TNFα-activated EC requires E-selectin, β 2 -integrins and FcγRIIa but not FcγRIIIb
To define the adhesion molecules active in this model, PMN, HL60 cells and HMEC- 
Expression of E-selectin and IL-8 via adenovirus infection allows IgG-mediated leukocyte adhesion
We therefore next explored whether provision of IL-8 by infection of MCEC-1 cells with an IL-8 adenovirus construct (adIL-8) would allow RMAC8-stimulated adhesion to occur on EC expressing E-selectin, maintaining ICAM-1 expression at basal levels.
In preliminary experiments, adIL-8 was titrated in HMEC-1 cells coinfected with adE-selectin and shown to lead to IL-8 release (as measured by ELISA, not shown),
and to enhance PMN arrest at >200 MOI ( Figure 4A ). As shown in Figure 4B , mAb RMAC8 significantly augmentated adhesion to EC infected with adE-selectin and a subthreshold concentration of adIL-8 (100 MOI), and this was significantly inhibited by antibodies to the IL-8 receptors CXCR-1 and CXCR-2. As shown in Figure 4C , anti-CXCR-1 and anti-CXCR-2 were subsequently found to inhibit fully the mAb RMAC8-dependent PMN adhesion to TNFα-stimulated HMEC-1 cells. Thus, the cooperation of E-selectin, FcγRIIa, CXCR-1/2 and β 2 integrins is both necessary and sufficient for mAb RMAC-8 augmented adhesion to EC under flow conditions.
Assembly of immune-complexes on EC leads to IL-8-independent FcγRIIIb-mediated leukocyte recruitment
Although our data so far indicated that FcγRIIa rather than FcγRIIIb mediates the increase in PMN adhesion to EC coated with monomeric IgG, a previous study investigating PMN adhesion to glass coated with immune-complexes has shown that 
selectin + ICAM-1 was inhibited fully anti-FcγRIIIb, whereas anti-FcγRIIa had no significant effect ( Figure 5D ). HL60 cells, which have a low expression of FcγRIIIb, did not show enhanced adhesion to RMAC8 + RbAMIg coated EC infected with adEselectin and adICAM-1 (data not shown). Taken together, these observations confirm that ligation of FcγRIIIb by immune-complexes is able to directly stimulate β 2 -integrin-mediated adhesion, but indicate that when EC are used as substrate there is requirement for initial selectin-mediated capture. When PMN adhesion was tested on TNFα-stimulated EC coated with RMAC8 + RbAMIg, immune-complex stimulated adhesion was completely inhibited by anti-FcγRIIa, whilst anti-FcγRIIIb had a lesser inhibitory effect that did not reach statistical significance in three experiments ( Figure   5E ). FcγRIIa therefore appears to be dominant when EC have been activated by TNFα.
AECA found in SLE augment PMN recruitment via cooperation between
FcγRIIa and CXCR1/2
Our data therefore demonstrate separate FcγRIIa-and FcγRIIIb-mediated mechanisms for IgG-mediated leukocyte adhesion to EC, and suggest that the critical determinants are whether EC are cytokine-activated and whether EC are coated with monomeric IgG or assembled immune-complexes. We therefore predicted that SLE antibodies would influence PMN-EC interactions by the FcγRIIa-mediated mechanism we had identified using mAb RMAC8. Sera from seventeen patients with SLE were screened for EC reactivity by a cell-based ELISA, using isotype-specific conjugates. The IgG reacting with HMEC-1 in the sera of these patients was shown to be entirely IgG 1 (not shown). Three sera with high AECA activity and three sera with low EC binding ( Figure 6A ) were separately pooled, and IgG purified from them on a Protein G Figure 6C ). As with mAb RMAC8, deposition of SLE IgG with high or low level AECA activity had no effect on PMN adhesion to HMEC-1 cells coinfected with E-selectin (100 MOI) and ICAM-1 (50 MOI) (not shown), but significantly increased PMN arrest on TNFα-activated EC ( Figure 6D ).
Furthermore, human AECA-stimulated PMN recruitment under these conditions was ablated by anti-FcγRIIa and not significantly influenced by anti-FcγRIIIb ( Figure 6E ).
As expected, human AECA-stimulated PMN recruitment on TNFα-activated EC was also inhibited by anti-E-selectin, anti-CD18 or a combination of anti-CXCR1 and anti-CXCR2 (not shown). Therefore, these experiments show for the first time that AECA found in SLE augment β 2 -integrin-dependent PMN adhesion to cytokineactivated EC by an FcγRIIa-mediated mechanism requiring costimulation via CXCR-1/2. , and also to lead to the rapid clustering of LFA-1 into high avidity patches on the PMN surface 44 . This raises the possibility that FcγRIIa might also cluster in response to IL-8 stimulation, 45 . It should also be borne in mind that combined ligation of CXCR1/2 and FcγRIIa may lead to synergistic activation of PI3K, which is critically involved in modulating PMN β 2 -integrin function 23;44 .
Although there may be cross-reactivity of AECA between human and mouse EC 46 Two technical points relating to the study merit discussion. The MCEC-1 cell line is derived from human cutaneous microvessels and provides an appropriate model of endothelium for a study on AECA in SLE. Although MCEC-1 cells respond well to
TNFα with respect to upregulation of ICAM-1 expression, only a subset of cells was induced to express E-selectin. Nevertheless, E-selectin was found to be critical for both FcγRIIa-and FcγRIIIb-mediated adhesion in response to IgG/AECA or immune-complexes, suggesting that an individual EC expressing E-selectin is probably sufficient for PMN capture in this system. Secondly, we used a combination This strategy avoids possible inhibitory effects on leukocyte activation/adhesion of presenting IL-8 in solution 52 , and should prove useful for studying the effects of other EC-derived chemoattractants on leukocyte-EC interactions.
It was not the intention of the present study to define the antigens with which AECA react, but rather to prove the principle that AECA could influence leukocyte recruitment under physiological flow conditions. By isolating IgG from patients with SLE we have shown that the basic mechanisms revealed with our model system apply also to putatively pathological human antibodies. Our study was predominantly conducted using a shear of 1. oxidative burst over the course of 1-2 hr, but extrapolating from their study to our own is difficult due to significant differences in the two assay systems 12 .
The observation that AECA found in SLE can amplify PMN-EC interactions suggests that patients with these antibodies may have disproportionate leukocyte recruitment in relation to the degree of endothelial activation. Inappropriate amplification of PMN-EC interactions may contribute to microvascular dysfunction and injury at times of systemic cytokine release, such as during disease flares. The data also suggest a mechanism whereby acute lupus flares may be triggered by infections 57 In conclusion, our data lead to a new paradigm for understanding PMN interactions Values are mean ± SEM of three experiments (*p<0.01, **p<0.03). 
